RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value: $1.54B (100.0% shares, 0.0% debt)

Holdings (27)

WVE WAVE LIFE SCIENCES LTD 18.7%
Value $287M Shares 7,512,049 Est. Cost $16.44 Unrealized +161.8%
ASND ASCENDIS PHARMA A S 18.3%
Value $282M Shares 4,240,536 Est. Cost $17.96 Unrealized
SOLID BIOSCIENCES INC 6.2%
Value $95.83M Shares 2,689,444 Est. Cost $7.50 Unrealized
ENDOCYTE INC 5.1%
Value $77.97M Shares 5,649,884 Est. Cost $7.70 Unrealized
MOMENTA PHARMACEUTICALS INC 4.9%
Value $75.72M Shares 3,702,533 Est. Cost $20.45 Unrealized
IMMUNOMEDICS INC 4.8%
Value $73.84M Shares 3,119,778 Est. Cost $23.67 Unrealized
MYOVANT SCIENCES LTD 4.2%
Value $64.73M Shares 2,830,455 Est. Cost $12.11 Unrealized
IFRX INFLARX NV 4.1%
Value $63.44M Shares 1,967,148 Est. Cost $20.89 Unrealized +65.4%
TGTX TG THERAPEUTICS INC 3.7%
Value $56.27M Shares 4,278,796 Est. Cost $13.19 Unrealized +4.3%
SAGE THERAPEUTICS INC 3.6%
Value $54.93M Shares 350,933 Est. Cost $164.71 Unrealized
ZOGENIX INC 3.3%
Value $50.62M Shares 1,145,268 Est. Cost $16.89 Unrealized
RYTM RHYTHM PHARMACEUTICALS INC 3.1%
Value $48.2M Shares 1,541,743 Est. Cost $27.34 Unrealized 0.0%
DICERNA PHARMACEUTICALS INC 3.1%
Value $48.19M Shares 3,933,489 Est. Cost $18.43 Unrealized
EIDOS THERAPEUTICS INC 2.9%
Value $43.99M Shares 2,162,671 Est. Cost $20.34 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 2.6%
Value $40.02M Shares 6,984,692 Est. Cost $7.39 Unrealized -25.5%
RA PHARMACEUTICALS INC 2.5%
Value $38.33M Shares 3,851,808 Est. Cost $8.78 Unrealized
KALA PHARMACEUTICALS INC 1.9%
Value $29.02M Shares 2,113,236 Est. Cost $22.84 Unrealized
APLS APELLIS PHARMACEUTICALS INC 1.3%
Value $19.8M Shares 900,000 Est. Cost $14.72 Unrealized +56.1%
CLEARSIDE BIOMEDICAL INC 1.1%
Value $16.3M Shares 1,525,000 Est. Cost $10.73 Unrealized
SCPHARMACEUTICALS INC 1.0%
Value $16.17M Shares 2,857,143 Est. Cost $12.09 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 0.9%
Value $14.35M Shares 1,121,153 Est. Cost $14.93 Unrealized -2.1%
KALV KALVISTA PHARMACEUTICALS INC 0.8%
Value $11.7M Shares 1,441,070 Est. Cost $9.16 Unrealized -3.7%
AVEO PHARMACEUTICALS INC 0.7%
Value $11.44M Shares 5,062,759 Est. Cost $2.59 Unrealized
SPRO SPERO THERAPEUTICS INC 0.7%
Value $10.88M Shares 741,647 Est. Cost $12.27 Unrealized +4.2%
GLYCOMIMETICS INC 0.3%
Value $4.09M Shares 253,547 Est. Cost $16.23 Unrealized
PROTEON THERAPEUTICS INC 0.2%
Value $3.277M Shares 1,337,462 Est. Cost $1.53 Unrealized
G1 THERAPEUTICS INC 0.1%
Value $1.738M Shares 40,000 Est. Cost $17.44 Unrealized